Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm operates through two segments, which include Medical Devices and Preservation Services. The medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, aortic aneurysms, and dissections, and, to a lesser extent, other conditions in cardiac and vascular surgery. The company has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products.
Mr. James Mackin is the Chairman of the Board of Artivion Inc, joining the firm since 2014.
What is the price performance of AORT stock?
The current price of AORT is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Artivion Inc?
Artivion Inc belongs to Health Care industry and the sector is Health Care
What is Artivion Inc market cap?
Artivion Inc's current market cap is $NaN
Is Artivion Inc a buy, sell, or hold?
According to wall street analysts, 10 analysts have made analyst ratings for Artivion Inc, including 4 strong buy, 7 buy, 2 hold, 0 sell, and 4 strong sell